Cargando…
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780445/ https://www.ncbi.nlm.nih.gov/pubmed/26934881 http://dx.doi.org/10.5009/gnl16024 |
| _version_ | 1782419763375374336 |
|---|---|
| author | Kim, Jae Hyun Cheon, Jae Hee |
| author_facet | Kim, Jae Hyun Cheon, Jae Hee |
| author_sort | Kim, Jae Hyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4780445 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47804452016-03-14 Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Kim, Jae Hyun Cheon, Jae Hee Gut Liver Editorial Editorial Office of Gut and Liver 2016-03 2016-03-15 /pmc/articles/PMC4780445/ /pubmed/26934881 http://dx.doi.org/10.5009/gnl16024 Text en Copyright © 2016 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Jae Hyun Cheon, Jae Hee Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis |
| title | Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis |
| title_full | Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis |
| title_fullStr | Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis |
| title_full_unstemmed | Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis |
| title_short | Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis |
| title_sort | understanding the role of adalimumab in the treatment of moderately to severely active ulcerative colitis |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780445/ https://www.ncbi.nlm.nih.gov/pubmed/26934881 http://dx.doi.org/10.5009/gnl16024 |
| work_keys_str_mv | AT kimjaehyun understandingtheroleofadalimumabinthetreatmentofmoderatelytoseverelyactiveulcerativecolitis AT cheonjaehee understandingtheroleofadalimumabinthetreatmentofmoderatelytoseverelyactiveulcerativecolitis |